2016 NMSHP Spring Meeting

  • Saturday, April 16, 2016
  • 7:15 AM - 12:30 PM
  • Domenici Center for Health Sciences Education

Registration

  • Pharmacist or industry professional member registration.
  • Pharmacist or industry professionals not current NMSHP members.
  • Student registration.
  • Technician registration

Registration is closed

Join us for a half-day meeting and obtain as many as four hours of CPE credit.


Location:
University of New Mexico North Campus (Health Sciences Center)
Domenici Center for Health Sciences Education
1001 Stanford NE
Albuquerque, NM 87106

Also broadcasted LIVE in Las Cruces, New Mexico at the Memorial Hospital in the Pinon A and B rooms.

Schedule of Events:
7:15 - 8:00 AM
Registration

7:50 – 8:00 AM
Welcoming Remarks
Jamie Glasgow, PharmD, NMSHP President

8:00 – 9:00 AM

The Safe Prescribing of Opioid Medications in Non-Cancer Pain: Using Opioid Medication in a Troubled Time

Ernest J Dole, PharmD, PhC, FASHP, BCPS

Program UAN #: 0039-0000-16-039-L05-P 0039-0000-16-039-L05-T

1.0 Credit Hours (0.1 CEUs)
Knowledge-based
This speaker has no financial conflicts of interest to disclose regarding this presentation.

At the completion of this activity, the participant will be able to:
Pharmacists:

Discuss the best practices for prescribing opioid medications.

Discern why buprenorphine is a safe pain medication.

Discuss the place of co-prescribing naloxone or patients being prescribed chronic opioid therapy (COT) for chronic non cancer pain (CNCP).

 

Pharmacy Technicians:

Discuss the role of the pharmacist & the pharmacist technician in the best practices for prescribing opioid medications.

Discuss why buprenorphine is a safer pain medication than morphine or oxycodone.

Discuss the role of the pharmacist & pharmacist technician in the of co-prescribing naloxone or patients being prescribed chronic opioid therapy (COT) for chronic non cancer pain (CNCP).

9:00 – 10:00 AM

Treatment of the Most Common Behavioral Disorders: Anxiety, Depression and Insomnia

Marlin C Hoover, PhD,  MSCP, ABPP-C
Program UAN#:
0039-0000-16-040-L04-P 0039-0000-16-040-L04-T

1.0 Credit Hours (0.1 CEUs)

Knowledge-based
This speaker has no financial conflicts of interest to disclose regarding this presentation.

At the completion of this activity, the participant will be able to:
Pharmacists:

The attendee will be able to list the most common anxiety and mood disorders and describe their presentations.

The attendee will be able to describe the factors which determine whether psychotropic medications are appropriate for the treatment of the patient.

 

Pharmacy Technicians:

List the most `common anxiety, sleep and mood disorders and describe their presentations.

Describe the factors which determine whether psychotropic medications are appropriate for the treatment of the patient.

Describe three factors which lead to the selection of specific classes of medications.


10:00 – 10:30 AM
Snack Break

10:30 – 11:30 AM

Take My Breath Away: COPD Update

Juliann Horne, PharmD, PhC, BCACP

Program UAN#: 0039-0000-16-041-L04-P 0039-0000-16-041-L04-T

1.0 Credit Hours (0.1 CEUs)
Knowledge-based
This speaker has no financial conflicts of interest to disclose regarding this presentation.

At the completion of this activity, the participant will be able to:
Pharmacists:

Describe signs, symptoms and classifications of chronic obstructive pulmonary disease (COPD).

Explain the role of pharmacotherapy for COPD.

Compare and contrast recently approved pharmacotherapeutic agents and inhaler devices for the treatment of COPD.

 

Pharmacy Technicians:

List signs and symptoms of COPD

List treatments and inhaler devices for COPD

Explain the role of pharmacotherapy for COPD

 

11:30 AM – 12:30 PM

Review of a Common and not so Common Pediatric Condition

Matthew London, PharmD
Program UAN#:
0039-0000-16-042-L04-P 0039-0000-16-042-L04-T

1.0 Credit Hours (0.1 CEUs)
Knowledge-based
This speaker has no financial conflicts of interest to disclose regarding this presentation.

At the completion of this activity, the participant will be able to:
Pharmacists:

Describe the pathophysiology of bronchiolitis.

Evaluate common treatment approaches to bronchiolitis and the supporting evidence.

Identify key differences in the management of diabetic ketoacidosis between pediatrics and adults.

 

Pharmacy Technicians:

Identify common medications used in the treatment of bronchiolitis and potential for errors.

Identify a potential consequence of delayed medication administration in diabetic ketoacidosis.

Identify commonly used IV fluids used to treat diabetic ketoacidosis.


CPE Credit
                                                                                                               

The University of New Mexico Continuing Education Program is approved by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmaceutical education. UAN 0039-0000-16-039-L05-P, 0039-0000-16-040-L04P, 0039-0000-16-041-L04P and 0039-0000-16-042-L04-L04P have been assigned to this Knowledge based program for Pharmacists. UAN 0039-0000-16-039-L05-T, 0039-0000-16-040-L04-T, 0039-0000-16-041-L04T and 0039-0000-16-042-L04T have been assigned to this Knowledge based program for Pharmacy Technicians. This program provides a total of 1.0 contact hours (.1 CEUs) of continuing education credit per session for a total of 4.0 contact hours (.4 CEUs). You must attend entire session, sign-in and complete evaluation and request for credit.



  • Home
  • 2016 NMSHP Spring Meeting
Powered by Wild Apricot Membership Software